These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Ablation of paroxysmal atrial fibrillation during coronary artery bypass grafting: 12 months' follow-up through implantable loop recorder. Pokushalov E; Romanov A; Cherniavsky A; Corbucci G; Pak I; Kareva Y; Karaskov A Eur J Cardiothorac Surg; 2011 Aug; 40(2):405-11. PubMed ID: 21601472 [TBL] [Abstract][Full Text] [Related]
11. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices. Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of atrial fibrillation burden after surgical ablation: relevancy of end-point criteria after radiofrequency ablation treatment of patients with lone atrial fibrillation. Beukema R; Beukema WP; Sie HT; Misier AR; Delnoy PP; Elvan A Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):956-9. PubMed ID: 19762419 [TBL] [Abstract][Full Text] [Related]
13. [Assessment of atrial fibrillation ablation outcome: from symptoms to continuous monitoring with an implantable loop recorder]. Rordorf R; Vicentini A; Landolina M G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):16S-21S. PubMed ID: 19195301 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Turakhia MP; Ullal AJ; Hoang DD; Than CT; Miller JD; Friday KJ; Perez MV; Freeman JV; Wang PJ; Heidenreich PA Clin Cardiol; 2015 May; 38(5):285-92. PubMed ID: 25873476 [TBL] [Abstract][Full Text] [Related]
15. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL; Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858 [TBL] [Abstract][Full Text] [Related]
16. Holter monitoring in the diagnosis of stroke mechanism. Shafqat S; Kelly PJ; Furie KL Intern Med J; 2004 Jun; 34(6):305-9. PubMed ID: 15228390 [TBL] [Abstract][Full Text] [Related]
17. Improved screening for silent atrial fibrillation after ischaemic stroke. Doliwa Sobocinski P; Anggårdh Rooth E; Frykman Kull V; von Arbin M; Wallén H; Rosenqvist M Europace; 2012 Aug; 14(8):1112-6. PubMed ID: 22308086 [TBL] [Abstract][Full Text] [Related]
18. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal? Di Cori A; Lilli A; Zucchelli G; Zaca V Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527 [TBL] [Abstract][Full Text] [Related]